Evaluating Khaya senegalensis for Dipeptidyl Peptidase-IV Inhibition Using in Vitro Analysis and Molecular Dynamic Simulation of Identified Bioactive Compounds
- PMID: 36565063
- DOI: 10.1002/cbdv.202200909
Evaluating Khaya senegalensis for Dipeptidyl Peptidase-IV Inhibition Using in Vitro Analysis and Molecular Dynamic Simulation of Identified Bioactive Compounds
Abstract
The dipeptidyl peptidase-IV (DPP-IV) inhibitory activity of Khaya senegalensis extracts was evaluated. The DPP-IV from a rat kidney was purified to a purification fold of 2.3. Among extracts from K. senegalensis, the hexane extract had the best DPP-IV inhibitory activity, with IC50 value of 1.56±0.61 μg/mL and was fractionated to eleven fractions (A-K). Fraction I had the best DPP-IV inhibition via uncompetitive pattern. GC-MS analysis of fraction I showed that the major bioactive compounds were 3-amino-3-hydroxyimino-N-phenylpropanamide (1) and 11-(2-cyclopenten-1-yl)undecanoic acid (2), with good binding affinities toward DPP-IV, based on molecular docking,. They were then subjected to molecular dynamic simulation using WEBGRO and utilizing a GROMACS system for 100 ns. The 3-amino-3-hydroxyimino-N-phenylpropanamide-DPP-IV complex was more stable and compact than the other complex. K. senegalensis contains compounds like 1 that might be used for the design of new DPP-IV inhibitors.
Keywords: Khaya senegalensis; Meliaceae; Type 2 diabetes; dipeptidyl peptidase IV; molecular docking.
© 2022 Wiley-VHCA AG, Zurich, Switzerland.
References
-
- M. J. Meneses, B. M. Silva, M. Sousa, R. Sa, P. F. Oliveira, M. G. Alves, ‘Antidiabetic drugs: mechanisms of action and potential outcomes on cellular metabolism’, Curr. Pharm. Des. 2015, 21, 3606-3620.
-
- N. H. Cho, J. Shaw, S. Karuranga, Y. Huang, J. da Rocha Fernandes, A. Ohlrogge, B. Malanda, ‘IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045’, Diabetes Res. Clin. Pract. 2018, 138, 271-281.
-
- J. Salas-Salvadó, M. Martinez-Gonzalez, M. Bulló, E. Ros, ‘The role of diet in the prevention of type 2 diabetes’, Nutr. Metab. Cardiovasc. Dis. 2011, 21, B32-B48.
-
- M. A. Ibrahim, A. Abdulkadir, A. Onojah, L. Sani, A. Adamu, H. Abdullahi, ‘Modulation of sialic acid levels among some organs during insulin resistance or hyperglycemic states’, Mol. Cell. Biochem. 2016, 411, 235-239.
-
- A.-M. Lambeir, C. Durinx, S. Scharpé, I. De Meester, ‘ Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV’, Crit. Rev. Clin. Lab. Sci. 2003, 40, 209-294.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous